Wilma D. Heemsbergen

Dose-Response in Radiotherapy for Localized Prostate Cancer: Results of the Dutch Multicenter Randomized Phase III Trial Comparing 68 Gy of Radiotherapy With 78 Gy

Stéphanie Peeters, Wilma D. Heemsbergen, P. Koper et al. · Journal of Clinical Oncology · 2006 · 971 citations · Full text

Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial

Luca Incrocci, Ruud C. Wortel, Wendimagegn Alemayehu et al. · The Lancet Oncology · 2016 · 463 citations

Urology, Surgical Oncology, Final Efficacy Results +7

Acute and late complications after radiotherapy for prostate cancer: Results of a multicenter randomized trial comparing 68 Gy to 78 Gy

Stéphanie Peeters, Wilma D. Heemsbergen, Wim L.J. van Putten et al. · International Journal of Radiation Oncology*Biology*Physics · 2005 · 442 citations

Urology, Radiation Medicine, Surgical Oncology +6

Update of Dutch Multicenter Dose-Escalation Trial of Radiotherapy for Localized Prostate Cancer

Abrahim Al‐Mamgani, Wim L.J. van Putten, Wilma D. Heemsbergen et al. · International Journal of Radiation Oncology*Biology*Physics · 2008 · 416 citations

Surgical Oncology, Urology, Radiation Therapy +5

Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial

Shafak Aluwini, Floris J. Pos, Erik C. Schimmel et al. · The Lancet Oncology · 2016 · 308 citations · Full text

Radiation Medicine, Radiation Therapy, Medicine +8